StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CannaPharmaRx's price to sales ratio was 0.8× on Oct 16, 2026, against 2.4× a year earlier. Over the last 3 years it ranged from 0.8× to 303.2×, with a median of 2.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 16, 20260.8×−1.2
2025Dec 31, 20252.0×−13.9
2024Dec 31, 202415.9×–

More CannaPharmaRx figures

See a number that looks wrong?